Par Pharmaceutical Companies to Report Fourth Quarter and Full Year 2009 Results on February 24, 2010
WOODCLIFF LAKE, N.J., Feb. 2 Par Pharmaceutical Companies, Inc. (NYSE: PRX) announced today that it will host a conference call and live webcast on Wednesday, February 24, 2010 at 8:30 am EST to review results for the fourth quarter and full year ended December 31, 2009. Par will release its financial results on February 24 before the market opens.
Access to the live webcast can be made via the Company's website at www.parpharm.com.
A replay of the conference call will be available for two weeks approximately one hour after the call.
Par Pharmaceutical Companies, Inc. is a US-based specialty pharmaceutical company. Through its wholly-owned subsidiary's two operating divisions, Par Pharmaceutical and Strativa Pharmaceuticals, it develops, manufactures and markets high barrier-to-entry generic drugs and niche, innovative proprietary pharmaceuticals. For press release and other company information, visit www.parpharm.com.
Dial-in Information ------------------- Domestic: 866-770-7129 International: 617-213-8067 Passcode: 49930027
SOURCE Par Pharmaceutical Companies, Inc.
You May Also Like